Erik Atkisson - Sep 22, 2021 Form 3 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
GC & Chief Compliance Officer
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Stock symbol
EIGR
Transactions as of
Sep 22, 2021
Transactions value $
$0
Form type
3
Date filed
10/1/2021, 04:34 PM
Next filing
Oct 1, 2021

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney